Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 8/12/2019
SIETES contiene 92850 citas

 
 
<< anterior 21 a 40 de 107 siguiente >>
Presentar resultados
Seleccionar todas
21.Tiene citas relacionadas
Schneider LS. Ginkgo biloba extract and preventing Alzheimer disease. JAMA 2008;300:2306-8. [Ref.ID 84567]
22.Tiene citas relacionadas Cita con resumen
DeKosky ST, Williamson JD, Fitzpatrick AL, Kronmal RA, Ives DG, Saxton JA, López OL, Burke G, Carlson MC, Fried LP, Kuller LH, Robbins JA, Tracy RP, Woolard NF, Dunn L, Snitz BE, Nahin RL, Furberg CD, for the Ginkgo Evaluation of Memory (GEM) Study Investigators. Ginkgo biloba for prevention of dementia. A randomized controlled trial. JAMA 2008;300:2253-62. [Ref.ID 84565]
23. Cita con resumen
Nelson HD. Menopause. Lancet 2008;371:760-70. [Ref.ID 82270]
24.Tiene citas relacionadas Cita con resumen
Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet 2007;370:185-91. [Ref.ID 80570]
25. Cita con resumen
Anónimo. Acúfenos y medicamentos. Boletín Terapéutico Andaluz 2007;23:5-8. [Ref.ID 80134]
26.
Singh SR, Levine MAH. Potential interactions between pharmaceuticals and natural health products in Canada. J Clin Pharmacol 2007;47:249-58. [Ref.ID 79247]
27.
Tomás-Guillén E, Farriols-Danés C, Cantarell-Aixendri C, Juárez-Giménez JC. Interacciones entre plantas medicinales y fármacos inmunodepresores. Med Clin (Barc) 2006;127:177-84. [Ref.ID 77545]
28.
DeKosky ST, Fitzpatrick A, Ives DG, Saxton J, Williamson J, López OL, Burke G, Fried L, Kuller LH, Robbins J, Tracy R, Woolard N, Dunn L, Kronmal R, Nahin R, Furberg C, for the GEMS Investigators. The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia. Contemp Clin Trials 2006;27:238-53. [Ref.ID 77108]
29.
Delgoda R, Westlake ACG. Herbal interactions involving cytochrome P450 enzymes: a mini review. Toxicol Rev 2005;23:239-49. [Ref.ID 74154]
30.
Anónimo. Taking herbal remedies may risk drug interactions. Ann Rheum Dis 2005;63:790. [Ref.ID 73862]
31.
Jiang X-M, Williams KM, Liauw WS, Ammit AJ, Roufogalis BD, Duke CC, Day RO, McLachlan AJ. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol 2005;59:425-32. [Ref.ID 73530]
32. Cita con resumen
Chow T, Browne V, Heileson LH, Wallace D, Anholm J, Green SM. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial. Arch Intern Med 2005;165:296-301. [Ref.ID 72800]
33.
Kelly JP, Kaufman DW, Kelley K, Rosenberg L, Anderson TE, Mitchell AA. Recent trends in use of herbal and other natural products. Arch Intern Med 2005;165:281-95. [Ref.ID 72799]
34. Cita con resumen
Jacoby D, Mohler III ER. Drug treatment of intermittent claudication. Drugs 2004;64:1657-70. [Ref.ID 70945]
35.Tiene citas relacionadas
Gertsch JH, Basnyat B, Johnson EW, Holck PS. Ginkgo biloba and acetazolamide for acute mountain sickness. Authors' reply. BMJ 2004;329:172. [Ref.ID 70810]
38. Cita con resumen
Grabe DW, Garrison GD. Comparison of natural product use between primary care and nephrology patients. Ann Pharmacother 2004;38:1169-72. [Ref.ID 70601]
39.Tiene citas relacionadas Cita con resumen
Schneider LS. AD2000: donepezil in Alzheimer's disease. Lancet 2004;363:2100-1. [Ref.ID 70557]
40. Cita con resumen
Juárez JC, Girona L. Plantas medicinales: toxicidad e interacciones con los medicamentos. Boletín Informativo sobre Medicamentos 2004;37:9-13. [Ref.ID 70305]
Seleccionar todas
 
<< anterior 21 a 40 de 107 siguiente >>